<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Diabetes and Metabolism via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Diabetes and Metabolism' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Diabetes+and+Metabolism&t=Diabetes+and+Metabolism&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 15:08:52 +0100</lastBuildDate>
        <item>
            <title>Use of clinical scores to detect dysglycaemia in overweight or obese women.</title>
            <link>http://www.medworm.com/index.php?rid=5662645&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22300975%26dopt%3DAbstract</link>
            <description>CONCLUSION: Performing OGTT in obese women selected on a simple clinical score is more sensitive to identify dysglycaemia than measuring FPG in all of them and may be cost-effective.
    PMID: 22300975 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5662645</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5662645</guid>        </item>
        <item>
            <title>Dental implants and diabetes: Conditions for success.</title>
            <link>http://www.medworm.com/index.php?rid=5662646&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22284547%26dopt%3DAbstract</link>
            <description>CONCLUSION: Implant surgery is never a matter of urgency; thus, diabetes patients with the best chances of success should be conjointly selected and prepared by both dental and diabetes clinicians.
    PMID: 22284547 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5662646</comments>
            <pubDate>Wed, 25 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5662646</guid>        </item>
        <item>
            <title>Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5625911&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22252014%26dopt%3DAbstract</link>
            <description>CONCLUSION: In recent years, considerable improvement has been observed in France regarding the follow-up of diabetic patients. Less extensive, but nonetheless significant, improvement has also been observed in glycaemic control. However, even though treatment decisions generally take renal function into account, some at-risk treatments are often still being used in patients with renal insufficiency.
    PMID: 22252014 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625911</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625911</guid>        </item>
        <item>
            <title>Inflammation and type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5625910&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22252015%26dopt%3DAbstract</link>
            <description>Authors: Calle MC, Fernandez ML
    Abstract
    Low-grade inflammation is a common feature in subjects with type 2 diabetes (T2D). Heart disease, the metabolic syndrome and T2D all have in common the increased concentration of circulatory cytokines as a result of inflammation. Inflammatory cytokines are produced by different cell types and secreted into the circulation, where they regulate different tissues through their local, central and peripheral actions. This review focuses on C-reactive protein (CRP), a well-established marker of the development of inflammation, on tumour necrosis factor (TNF)-α, an inflammatory marker strongly associated with diabetes, and on adiponectin, a cytokine produced by adipose tissue and associated with insulin sensitivity. While it is clear from the lite...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5625910</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5625910</guid>        </item>
        <item>
            <title>Improvement of psoriasis during exenatide treatment in a patient with diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5580014&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22227407%26dopt%3DAbstract</link>
            <description>CONCLUSION: There was a major and rapid improvement in psoriasis in our patient with T2D following treatment with exenatide. A possible mechanism might be through direct modulation of the immune system by GLP-1 receptor agonists.
    PMID: 22227407 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580014</comments>
            <pubDate>Fri, 06 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5580014</guid>        </item>
        <item>
            <title>Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5566757&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22209680%26dopt%3DAbstract</link>
            <description>Authors: Vergès B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E, Ducrocq G, Elbaz M, Fredenrich A, Gourdy P, Henry P, Lairez O, Leguerrier AM, Monpère C, Moulin P, Vergès-Patois B, Roussel R, Steg G, Valensi P, 
    Abstract
    The Diabetes and Cardiovascular Disease study group of the Société francophone du diabète (SFD, French Society of Diabetes) in collaboration with the Société française de cardiologie (SFC, French Society of Cardiology) have devised a consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome (ACS); in particular, it includes the different phases of ACS [the intensive care unit (ICU) period, the post-ICU period and the short-term follow-up period after discharge, including ca...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5566757</comments>
            <pubDate>Fri, 30 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5566757</guid>        </item>
        <item>
            <title>DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials.</title>
            <link>http://www.medworm.com/index.php?rid=5552239&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22197148%26dopt%3DAbstract</link>
            <description>Authors: Scheen AJ
    Abstract
    Dipeptidyl peptidase-4 (DPP-4) inhibitors offer new options for the management of type 2 diabetes. Direct comparisons with active glucose-lowering comparators in drug-naive patients have demonstrated that DPP-4 inhibitors exert slightly less pronounced HbA(1c) reduction than metformin (with the advantage of better gastrointestinal tolerability) and similar glucose-lowering effects as with a thiazolidinedione (TZD; with the advantage of no weight gain). In metformin-treated patients, gliptins were associated with similar HbA(1c) reductions compared with a sulphonylurea (SU; with the advantage of no weight gain, considerably fewer hypoglycaemic episodes and no need for titration) and a TZD (with the advantage of no weight gain and better overall tolerabili...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552239</comments>
            <pubDate>Wed, 21 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5552239</guid>        </item>
        <item>
            <title>The Barriers to Physical Activity in Type 1 Diabetes (BAPAD-1) scale: Predictive validity and reliability.</title>
            <link>http://www.medworm.com/index.php?rid=5537545&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22192621%26dopt%3DAbstract</link>
            <description>CONCLUSION: The BAPAD-1 scale is a reliable and valid tool for assessing salient barriers to physical activity. In future, this scale could be used to describe the factors accounting for physical activity, and for planning interventions aimed at promoting physical activity among adults with type 1 diabetes.
    PMID: 22192621 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537545</comments>
            <pubDate>Tue, 20 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5537545</guid>        </item>
        <item>
            <title>Insulin therapy for diabetes mellitus: Treatment regimens and associated costs.</title>
            <link>http://www.medworm.com/index.php?rid=5537547&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22172400%26dopt%3DAbstract</link>
            <description>CONCLUSION: Considerable heterogeneity is found in insulin treatment regimens used in everyday diabetes care. Payers should consider the full costs associated with the use of insulin rather than the cost of insulin alone. Treatment algorithms to harmonize insulin therapy should help to improve care, while encouraging patients to self-inject insulin should help to reduce costs.
    PMID: 22172400 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537547</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5537547</guid>        </item>
        <item>
            <title>Screening for deprivation using the EPICES score: A tool for detecting patients at high risk of diabetic complications and poor quality of life.</title>
            <link>http://www.medworm.com/index.php?rid=5537546&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22172401%26dopt%3DAbstract</link>
            <description>CONCLUSION: In this diabetic population, deprivation and glycaemic control were not associated. However, more deprived subjects with diabetes were at higher risk of renal disease. A deprived state was related to an altered quality of life as assessed by the SF-36 score.
    PMID: 22172401 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537546</comments>
            <pubDate>Tue, 13 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5537546</guid>        </item>
        <item>
            <title>Adherence to breast and cervical cancer screening in Spanish women with diabetes: Associated factors and trend between 2006 and 2010.</title>
            <link>http://www.medworm.com/index.php?rid=5426756&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22078638%26dopt%3DAbstract</link>
            <description>CONCLUSION: Spanish women with diabetes consistently underuse breast and cervical cancer screening tests compared with non-diabetic women. The decline in mammography uptake rates needs to be carefully monitored and may even call for intervention.
    PMID: 22078638 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426756</comments>
            <pubDate>Wed, 09 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426756</guid>        </item>
        <item>
            <title>Staphylococcus simulans osteitis in a diabetic patient.</title>
            <link>http://www.medworm.com/index.php?rid=5426757&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22074636%26dopt%3DAbstract</link>
            <description>Authors: Désidéri-Vaillant C, Nédelec Y, Guichon JM, Le Louarn S, Noyer V, Sapin-Lory J, Le Guen P, Nicolas X
    Abstract
    Staphylococcus simulans was identified as the aetiological agent of osteitis in a diabetic woman. Its identifying characteristics and antibiogram were confirmed. Diabetic foot frequently becomes infected and the spread of infection to bone is a major causal factor behind lower-limb amputation. Early diagnosis and appropriate treatment are essential in such cases.
    PMID: 22074636 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426757</comments>
            <pubDate>Tue, 08 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426757</guid>        </item>
        <item>
            <title>The metabolic syndrome, incidence of diabetes and mortality among the elderly: The Italian Longitudinal Study of Ageing.</title>
            <link>http://www.medworm.com/index.php?rid=5426759&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22071281%26dopt%3DAbstract</link>
            <description>CONCLUSION: The MetS is associated with the incidence of diabetes, and the synergy between the MetS and diabetes is an important risk factor for all-cause mortality in elderly subjects.
    PMID: 22071281 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426759</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426759</guid>        </item>
        <item>
            <title>Squatting, a posture test for studying cardiovascular autonomic neuropathy in diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5426758&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22071282%26dopt%3DAbstract</link>
            <description>Authors: Philips JC, Marchand M, Scheen AJ
    Abstract
    Cardiovascular autonomic neuropathy (CAN) is a frequent complication of diabetes mellitus, which is associated with increased morbidity and mortality. It involves both the parasympathetic and sympathetic nervous systems, and may be diagnosed by classical dynamic tests with measurements of heart rate (HR) and/or arterial blood pressure (BP). An original squat test (1-min standing, 1-min squatting, 1-min standing) was used with continuous monitoring of HR and BP, using a Finapres(®) device. This active test imposes greater postural stress than the passive head-up tilt test, and provokes large changes in BP and HR that can be analyzed to derive indices of CAN. In healthy subjects, squatting is associated with BP increases and HR dec...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426758</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426758</guid>        </item>
        <item>
            <title>Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies.</title>
            <link>http://www.medworm.com/index.php?rid=5426760&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22056307%26dopt%3DAbstract</link>
            <description>CONCLUSION: The aetiology of diabetic ED is multifactorial. Endothelial dysfunction is the link between diabetes-induced ED and coronary artery disease. A global approach is needed for the successful management of diabetic ED.
    PMID: 22056307 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5426760</comments>
            <pubDate>Thu, 03 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5426760</guid>        </item>
        <item>
            <title>Is it important to consider how hyperinsulinaemic-euglycaemic clamp results are expressed?</title>
            <link>http://www.medworm.com/index.php?rid=5382736&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030239%26dopt%3DAbstract</link>
            <description>Authors: Disse E, Rabasa-Lhoret R, Laville M, Bastard JP
    PMID: 22030239 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5382736</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5382736</guid>        </item>
        <item>
            <title>Quarterly individual outpatients lifestyle counseling after initial inpatients education on type 2 diabetes: The REDIA Prev-2 randomized controlled trial in Reunion Island.</title>
            <link>http://www.medworm.com/index.php?rid=5382735&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030240%26dopt%3DAbstract</link>
            <description>CONCLUSION: In this study of adults with T2D, patients significantly improved their metabolic control, and dietary and exercise habits, 1year after receiving intensive inpatients education, whereas subsequent quarterly outpatients counseling visits with nurses and dietitians have not demonstrated any superiority compared with the usual care.
    PMID: 22030240 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5382735</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5382735</guid>        </item>
        <item>
            <title>Haemodynamic changes during a squat test, pulsatile stress and indices of cardiovascular autonomic neuropathy in patients with long-duration type 1 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5382734&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030241%26dopt%3DAbstract</link>
            <description>CONCLUSION: The use of RR E/I ratios to separate T1DM patients allows the detection of other CAN markers during an orthostatic posture test, but with no significant differences in pulsatile stress or microalbuminuria. In this context, squatting-derived baroreflex gain appears to be more informative.
    PMID: 22030241 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5382734</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5382734</guid>        </item>
        <item>
            <title>Aortic stiffness, inflammation, denutrition and type 2 diabetes in the elderly.</title>
            <link>http://www.medworm.com/index.php?rid=5382733&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030242%26dopt%3DAbstract</link>
            <description>CONCLUSION: In this very elderly population, although marginally significant on crude analysis, PWV, but not systolic or pulse pressure, was a powerful determinant of total mortality after taking into account the important role of type 2 diabetes. In diabetics, inflammation and denutrition predominated over mechanical factors.
    PMID: 22030242 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5382733</comments>
            <pubDate>Mon, 24 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5382733</guid>        </item>
        <item>
            <title>Patients' education, and its impact on care outcomes, resource consumption and working conditions: Data from the International Diabetes Management Practices Study (IDMPS).</title>
            <link>http://www.medworm.com/index.php?rid=5382737&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22019715%26dopt%3DAbstract</link>
            <description>CONCLUSION: Diabetes education is an efficient tool for improving care outcomes without having a major impact on healthcare costs.
    PMID: 22019715 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5382737</comments>
            <pubDate>Fri, 21 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5382737</guid>        </item>
        <item>
            <title>Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5316302&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21996253%26dopt%3DAbstract</link>
            <description>CONCLUSION: In T2DM patients, serum osteocalcin levels were associated with parameters of atherosclerosis, suggesting that osteocalcin is involved not only in bone metabolism, but also in atherosclerotic disease.
    PMID: 21996253 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316302</comments>
            <pubDate>Tue, 11 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5316302</guid>        </item>
        <item>
            <title>Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women.</title>
            <link>http://www.medworm.com/index.php?rid=5283271&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21963427%26dopt%3DAbstract</link>
            <description>CONCLUSION: Overweight and obese women have an increased risk rate of macrosomia that can be limited by well-controlled weight gain during pregnancy. There was also a significantly higher rate of surgical delivery in the obese compared with the normal weight group that was, however, independent of excessive weight gain during pregnancy.
    PMID: 21963427 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5283271</comments>
            <pubDate>Thu, 29 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5283271</guid>        </item>
        <item>
            <title>Crossover and maximal fat-oxidation points in sedentary healthy subjects: Methodological issues.</title>
            <link>http://www.medworm.com/index.php?rid=5283278&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21944864%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our data show that, to assess the crossover point and LIPOX(max) values for research purposes, the protocol must be based on the measured MAP rather than on a theoretical value. Such a determination should improve individualization of training for initially sedentary subjects.
    PMID: 21944864 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5283278</comments>
            <pubDate>Fri, 23 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5283278</guid>        </item>
        <item>
            <title>The association between leptin and insulin levels in adults with cystic fibrosis.</title>
            <link>http://www.medworm.com/index.php?rid=5234698&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21925915%26dopt%3DAbstract</link>
            <description>CONCLUSION: This study suggests a potential role of insulin in regulating leptin levels in adults with stable CF.
    PMID: 21925915 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5234698</comments>
            <pubDate>Fri, 16 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5234698</guid>        </item>
        <item>
            <title>Prevalence and pattern of hand soft-tissue changes in type 2 diabetes mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=5234699&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21917496%26dopt%3DAbstract</link>
            <description>CONCLUSION: Hand changes are more prevalent and severe in patients with T2DM, and are correlated with age, duration of diabetes and microvascular complications.
    PMID: 21917496 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5234699</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5234699</guid>        </item>
        <item>
            <title>The effects of adding group-based lifestyle counselling to individual counselling on changes in plasma glucose levels in a randomized controlled trial: The Inter99 study.</title>
            <link>http://www.medworm.com/index.php?rid=5221225&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21900030%26dopt%3DAbstract</link>
            <description>CONCLUSION: Offering additional group-based intervention to a high-risk population subgroup had no clinical effects on changes in plasma glucose beyond those of individualized multifactorial interventions.
    PMID: 21900030 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221225</comments>
            <pubDate>Mon, 05 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221225</guid>        </item>
        <item>
            <title>Telemedicine and diabetes: Achievements and prospects.</title>
            <link>http://www.medworm.com/index.php?rid=5221226&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21889388%26dopt%3DAbstract</link>
            <description>Authors: Franc S, Daoudi A, Mounier S, Boucherie B, Dardari D, Laroye H, Neraud B, Requeda E, Canipel L, Charpentier G
    Abstract
    Health authorities currently have high expectations for telemedicine (TM), as it addresses several major challenges: to improve access to healthcare (especially for patients in underserved or remote areas); to overcome the scarcity of specialists faced with epidemic disease; and to reduce the costs of healthcare while improving quality. The aims of TM in the field of diabetes differ according to the type of diabetes. In type 1 diabetes (T1DM) associated with complex insulin regimens, the goal of TM is to help patients achieve better control of their blood glucose levels through accurate adjustment of insulin doses. In type 2 diabetes (T2DM), while therapeu...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5221226</comments>
            <pubDate>Wed, 31 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5221226</guid>        </item>
        <item>
            <title>Beyond glucose lowering: Glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.</title>
            <link>http://www.medworm.com/index.php?rid=5180154&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21871831%26dopt%3DAbstract</link>
            <description>CONCLUSION: These compounds may play an important role in the treatment of patients with T2DM as their potential effects go beyond glucose-lowering (weight loss, potential improvement of cardiovascular risk factors). However, to better understand their place in the management of T2DM, further experimental and clinical prospective studies are required.
    PMID: 21871831 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5180154</comments>
            <pubDate>Tue, 23 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5180154</guid>        </item>
        <item>
            <title>Effects of fasting and/or postprandial glucose on heart rate recovery in patients with coronary heart disease.</title>
            <link>http://www.medworm.com/index.php?rid=5180155&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21868273%26dopt%3DAbstract</link>
            <description>CONCLUSION: Both raised FPG and decreased HRR are independent predictors of total and cardiovascular (CV) mortality in subjects with CHD. Our data suggest that the mortality risk associated with elevated FPG may in part be due to deleterious effects on autonomic regulation of CV function, as reflected by lower HRR. Further studies are required to determine whether or not non-pharmacological and/or pharmacological treatments of increased fasting glucose have a beneficial influence on HRR.
    PMID: 21868273 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5180155</comments>
            <pubDate>Mon, 22 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5180155</guid>        </item>
        <item>
            <title>Failure to increase postprandial blood flow in subcutaneous adipose tissue is associated with tissue resistance to adrenergic stimulation.</title>
            <link>http://www.medworm.com/index.php?rid=5160154&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21865069%26dopt%3DAbstract</link>
            <description>CONCLUSION: These data suggest that the lack of glucose-stimulated ATBF is associated with resistance to sympathetic activation in adipose tissue.
    PMID: 21865069 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5160154</comments>
            <pubDate>Sun, 21 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5160154</guid>        </item>
        <item>
            <title>Painful diabetic neuropathy: Diagnosis and management.</title>
            <link>http://www.medworm.com/index.php?rid=5108425&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21820345%26dopt%3DAbstract</link>
            <description>Authors: Hartemann A, Attal N, Bouhassira D, Dumont I, Gin H, Jeanne S, Said G, Richard JL, 
    The prevalence of painful diabetic peripheral neuropathy (PDN) is about 20% in patients with type 2 diabetes and 5% in those with type 1. Patients should be systematically questioned concerning suggestive symptoms, as they are not usually volunteers. As PDN is due to small-fibre injury, the 10g monofilament pressure test as well as the standard electrophysiological procedures may be normal. Diagnosis is based on clinical findings: type of pain (burning discomfort, electric shock-like sensation, aching coldness in the lower limbs); time of occurrence (mostly at rest and at night); and abnormal sensations (such as tingling or numbness). The DN4 questionnaire is an easy-to-use validated diagnostic...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108425</comments>
            <pubDate>Tue, 02 Aug 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108425</guid>        </item>
        <item>
            <title>Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5108426&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21802332%26dopt%3DAbstract</link>
            <description>CONCLUSION: Prolonged fasting is possible at home in patients with type 1 diabetes, provided the basal dose is adjusted. The use of CGMS is not necessary, but offers useful information on the patient's IG profile during the fast.
    PMID: 21802332 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108426</comments>
            <pubDate>Tue, 26 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108426</guid>        </item>
        <item>
            <title>Cell-based therapy of diabetes: What are the new sources of beta cells?</title>
            <link>http://www.medworm.com/index.php?rid=5108427&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21778101%26dopt%3DAbstract</link>
            <description>Authors: Soggia A, Hoarau E, Bechetoille C, Simon MT, Heinis M, Duvillié B
    Diabetes affects 246 million people around the world. To date, no definitive cure has been discovered. Recent clinical trials have shed light on the possibility of successfully transplanting adult pancreatic islets into type 1 diabetic recipients. However, despite encouraging efforts to improve such protocols, the poor availability of pancreatic islets remains a limiting parameter for these transplantation programmes. In the present review, different strategies to obtain other sources of islet beta cells are discussed.
    PMID: 21778101 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108427</comments>
            <pubDate>Mon, 18 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108427</guid>        </item>
        <item>
            <title>Silent myocardial ischaemia and risk factors in a diabetic Afro-Caribbean population.</title>
            <link>http://www.medworm.com/index.php?rid=5108429&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21764347%26dopt%3DAbstract</link>
            <description>CONCLUSION: The prevalence of SMI in our Afro-Caribbean diabetic population was 23.1%. Searching for a personal history of cardiovascular disease and LVH may help to identify patients who need to be screened for SMI.
    PMID: 21764347 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108429</comments>
            <pubDate>Thu, 14 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108429</guid>        </item>
        <item>
            <title>Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=5108428&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21764620%26dopt%3DAbstract</link>
            <description>CONCLUSION: The rate of vitamin D deficiency was high in our T2D patients, and was associated with the VDR gene FokI and ApaI polymorphisms and cardiovascular risk profile. Measurements of vitamin D may help to detect T2D patients with cardiovascular risk, and VDR polymorphisms might explain why vitamin D deficiency is so frequently seen in some T2D patients.
    PMID: 21764620 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108428</comments>
            <pubDate>Wed, 13 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108428</guid>        </item>
        <item>
            <title>Effects of periodontal therapy on glucose management in people with diabetes mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=5108430&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21757386%26dopt%3DAbstract</link>
            <description>CONCLUSION: IPT resulted in greater improvement of gingival health in patients with DM. Improved oral health in those with type 2 DM may have an effect on medium-term glucose management and could possibly lead to long-term health benefits. (ISRCTN00559156).
    PMID: 21757386 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5108430</comments>
            <pubDate>Mon, 11 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5108430</guid>        </item>
        <item>
            <title>Association analysis of proopiomelanocortin (POMC) haplotypes in type 1 diabetes in a UK population.</title>
            <link>http://www.medworm.com/index.php?rid=5012172&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21723177%26dopt%3DAbstract</link>
            <description>CONCLUSION: The POMC SNP haplotype GGCGAG may have a protective effect against T1D in the UK population. However, this finding needs to be replicated, and the cellular and molecular processes influenced by this POMC haplotype determined to fully appreciate its impact.
    PMID: 21723177 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5012172</comments>
            <pubDate>Tue, 28 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5012172</guid>        </item>
        <item>
            <title>Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.</title>
            <link>http://www.medworm.com/index.php?rid=5012173&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21715211%26dopt%3DAbstract</link>
            <description>CONCLUSION: Sudoscan™ is a reproducible technique with results that are not influenced by blood glucose levels. Sweating status may be a quantitative indicator of the severity of polyneuropathy that may be useful for the early prevention of foot skin lesions.
    PMID: 21715211 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5012173</comments>
            <pubDate>Sun, 26 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5012173</guid>        </item>
        <item>
            <title>Fulminant type 1 diabetes mellitus-like presentation in a Hispanic woman in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=4969130&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21684789%26dopt%3DAbstract</link>
            <description>CONCLUSION: Fulminant type 1 diabetes mellitus is a recently described presentation of diabetes mellitus that has been predominately reported in Japan and other Asian countries. The classical presentation includes rapid onset on ketosis within 1week of symptoms of hyperglycaemia, with a near-normal glycohaemoglobin and absence of C-peptide. With the majority of case being reported from Asia, it has been hypothesized that there is a genetic determent that predisposes Asian individuals to develop fulminant type 1 diabetes mellitus. The addition of the case to the medical literature expands the focus of fulminant type 1 diabetes mellitus beyond the Asian population and supports the need that further research.
    PMID: 21684789 [PubMed - as supplied by publisher] (Source: Diabetes and Metabol...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969130</comments>
            <pubDate>Thu, 16 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969130</guid>        </item>
        <item>
            <title>Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications.</title>
            <link>http://www.medworm.com/index.php?rid=4969131&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21683639%26dopt%3DAbstract</link>
            <description>CONCLUSION: There was an HNF1A-MODY pick-up rate of 30.5% and an HNF4A-MODY pick-up rate of 6% in Irish MODY families. Genetically confirmed MODY has significant therapeutic implications.
    PMID: 21683639 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969131</comments>
            <pubDate>Tue, 14 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969131</guid>        </item>
        <item>
            <title>Estimation of renal function in patients with diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4969133&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21680218%26dopt%3DAbstract</link>
            <description>Authors: Rigalleau V, Beauvieux MC, Gonzalez C, Raffaitin C, Lasseur C, Combe C, Chauveau P, De la Faille R, Rigothier C, Barthe N, Gin H
    Diabetes is the leading cause of chronic kidney disease (CKD), which makes estimation of renal function crucial. Serum creatinine is not an ideal marker of glomerular filtration rate (GFR), which also depends on digestive absorption, and the production of creatinine in muscle and its tubular secretion. Formulas have been devised to estimate GFR from serum creatinine but, given the wide range of GFR, proteinuria, body mass index and specific influence of glycaemia on GFR, the uncertainty of these estimations is a particular concern for patients with diabetes. The most popular recommended formulas are the simple Cockcroft-Gault equation, which is inacc...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969133</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969133</guid>        </item>
        <item>
            <title>Number of children and change in markers of metabolic health over 9-years in men and women. Data from the DESIR study.</title>
            <link>http://www.medworm.com/index.php?rid=4969132&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21680219%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The number of children a person has is associated with changes in metabolic health indices long after childbirth for both men and women. The distinct gender differences in deterioration of metabolic health indices emphasize that childbearing and child-rearing are likely to have differential influences on metabolic health.
    PMID: 21680219 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969132</comments>
            <pubDate>Mon, 13 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969132</guid>        </item>
        <item>
            <title>Post-bypass hypoglycaemia: A review of current findings.</title>
            <link>http://www.medworm.com/index.php?rid=4969134&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21676638%26dopt%3DAbstract</link>
            <description>Authors: Ritz P, Hanaire H
    Gastric bypass is one of the most efficient strategies for long-term weight loss and reduction of the comorbidities associated with morbid obesity. Of the complications secondary to gastric bypass, hypoglycaemic episodes have so far been poorly studied. The present study is a comprehensive report of the fewer than 100 cases described in the literature. It shows that strict diagnostic criteria should be applied to differentiate true intense neuroglucopenic symptoms associated with low glucose values (&amp;lt;2.8 mmol/L) from the more frequent symptoms of the dumping syndrome and those occurring in the context of lower-than-normal plasma glucose concentrations. The pancreatic beta-cell hyperfunction initially deemed responsible for hypoglycaemic episodes because ...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969134</comments>
            <pubDate>Sun, 12 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969134</guid>        </item>
        <item>
            <title>Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=4969135&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21665509%26dopt%3DAbstract</link>
            <description>CONCLUSION: These findings provide evidence that the PNPLA3 SNP rs738409 contributes to risk for increased liver fat content in African Americans with T2DM, an effect that appears to be independent from serum lipids. Although African Americans are less susceptible to fatty liver than European Americans, PNPLA3 appears to be a risk locus for hepatic steatosis in diabetic African Americans.
    PMID: 21665509 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969135</comments>
            <pubDate>Thu, 09 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969135</guid>        </item>
        <item>
            <title>Effect of NF-κB decoy on insulin resistance of adipocytes from patients with type 2 diabetes mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=4969136&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21664164%26dopt%3DAbstract</link>
            <description>CONCLUSION: Abdominal subcutaneous fat cells from T2DM patients display signs of insulin resistance and microinflammatory status. NF-κB decoy molecules inhibited NF-κB overactivation and also partly reversed insulin resistance. These results provide evidence of a link between inflammation and insulin resistance in T2DM cells, suggesting a potential contribution of inflammation to the mechanism of insulin resistance.
    PMID: 21664164 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4969136</comments>
            <pubDate>Tue, 07 Jun 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4969136</guid>        </item>
        <item>
            <title>Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.</title>
            <link>http://www.medworm.com/index.php?rid=4922363&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21636306%26dopt%3DAbstract</link>
            <description>CONCLUSION: These results suggest that PEDF abrogates AGE-induced oxidative stress and apoptosis in retinal pericytes via the Src pathway, thereby suggesting that PEDF is an effective therapeutic agent for the treatment of loss of pericytes in early diabetic retinopathy.
    PMID: 21636306 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4922363</comments>
            <pubDate>Mon, 30 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4922363</guid>        </item>
        <item>
            <title>Benfluorex: Analysis of a drug-related public health crisis.</title>
            <link>http://www.medworm.com/index.php?rid=4876581&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21612964%26dopt%3DAbstract</link>
            <description>Authors: Menard J
    
    PMID: 21612964 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4876581</comments>
            <pubDate>Sun, 22 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4876581</guid>        </item>
        <item>
            <title>Poor self-rated health is not associated with a high total allostatic load in type 2 diabetic patients - But high blood pressure is.</title>
            <link>http://www.medworm.com/index.php?rid=4876582&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21596605%26dopt%3DAbstract</link>
            <description>CONCLUSION: The absence of an association between allostatic load and SRH in diabetic individuals contrasts with previous findings in non-diabetic women, and shows that it is hazardous to apply findings in one population to another, especially diabetic and non-diabetic populations.
    PMID: 21596605 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4876582</comments>
            <pubDate>Mon, 16 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4876582</guid>        </item>
        <item>
            <title>Patients' impatience is an independent determinant of poor diabetes control.</title>
            <link>http://www.medworm.com/index.php?rid=4823666&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21550831%26dopt%3DAbstract</link>
            <description>CONCLUSION: An impatient relationship to temporality was found associated with non-adherence to medication and uncontrolled HbA(1c) in type 2 diabetic patients. Treatment strategies for chronic diseases should be tailored according to this novel dimension of psychology.
    PMID: 21550831 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4823666</comments>
            <pubDate>Thu, 05 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4823666</guid>        </item>
        <item>
            <title>Non-traumatic rhabdomyolysis and diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4823665&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21550832%26dopt%3DAbstract</link>
            <description>Authors: Sani MA, Campana-Salort E, Begu-Lecorroller A, Baccou M, Valéro R, Vialettes B
    The present clinical report describes the case of a spontaneously resolving rhabdomyolysis episode in a type 1 diabetic patient, who presented with multiple risk factors of this muscle complication, including uncontrolled brittle diabetes with sequences of hyper- and hypoglycaemic episodes in the same day, caloric restriction and intensive exercise. It should be borne in mind that rhabdomyolysis is not particularly rare in diabetes and can be severe. To raise clinicians' awareness of a possible rhabdomyolysis diagnosis, the various clinical conditions that are likely to lead to this complication in diabetic patients are also reviewed here.
    PMID: 21550832 [PubMed - as supplied by publisher] (Sou...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4823665</comments>
            <pubDate>Thu, 05 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4823665</guid>        </item>
        <item>
            <title>Functional glucokinase regulator gene variants have inverse effects on triglyceride and glucose levels, and decrease the risk of obesity in children.</title>
            <link>http://www.medworm.com/index.php?rid=4823667&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21511510%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our findings confirm the inverse modulating effect of functional GCKR variants on triglycerides and glucose levels in obese paediatric patients and healthy normal-weight controls. The results of our study strongly suggest that the minor alleles confer protection against the development of obesity in children. The findings also suggest that the minor alleles of functional GCKR may protect against diabetes and the metabolic syndrome in adults.
    PMID: 21511510 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4823667</comments>
            <pubDate>Mon, 18 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4823667</guid>        </item>
        <item>
            <title>Immune cells in adipose tissue: Key players in metabolic disorders.</title>
            <link>http://www.medworm.com/index.php?rid=4823668&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21507694%26dopt%3DAbstract</link>
            <description>Authors: Lolmède K, Duffaut C, Zakaroff-Girard A, Bouloumié A
    Obesity, defined as the excess development of adipose tissue, is an important risk factor for metabolic and cardiovascular diseases such as type 2 diabetes, hypertension and atherosclerosis. Over the past few years, metabolic inflammation has emerged as a major process underlying the link between obesity and its associated pathologies. Adipose tissue appears to play a primary and crucial role as a source and site of inflammation. Accumulation of immune cells within adipose tissue occurs in obese conditions. The present review focuses on the relationship between adipose tissue and immune cells, including macrophages, dendritic cells, T and B lymphocytes, and natural killer cells, in both the physiological state and under ...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4823668</comments>
            <pubDate>Sun, 17 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4823668</guid>        </item>
        <item>
            <title>Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 Entred Surveys).</title>
            <link>http://www.medworm.com/index.php?rid=4663780&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21435929%26dopt%3DAbstract</link>
            <description>CONCLUSION: Elderly people with type 2 diabetes are receiving better quality of care and have better control of cardiovascular risk factors than before. However, improvement is still required, in particular by performing better screening for complications. In this patient population, it is important to carefully monitor the risks for hypoglycaemia, hypotension, malnutrition and contraindications related to renal function.
    PMID: 21435929 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4663780</comments>
            <pubDate>Tue, 22 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4663780</guid>        </item>
        <item>
            <title>How can we measure insulin sensitivity/resistance?</title>
            <link>http://www.medworm.com/index.php?rid=4663779&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21435930%26dopt%3DAbstract</link>
            <description>Authors: Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP
    Insulin resistance represents a major public health problem, as it plays a major role in the pathophysiology of type 2 diabetes mellitus; it is also associated with increased cardiovascular risk and atherogenic dyslipidaemia, and is a central component of the cluster of metabolic abnormalities that comprise the metabolic syndrome. Thus, the development of tools to quantify insulin sensitivity/resistance has been the main objective of a number of studies. Insulin resistance can be estimated with the use of several biological measurements that evaluate different aspects of this complex situation. To that end, it requires various resources, ranging from just a single fasting blood sample for simple indices...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4663779</comments>
            <pubDate>Tue, 22 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4663779</guid>        </item>
        <item>
            <title>Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: Association with microalbuminuria and silent coronary artery disease.</title>
            <link>http://www.medworm.com/index.php?rid=4604579&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21398163%26dopt%3DAbstract</link>
            <description>CONCLUSION: LV hypertrophy was found in one-third of asymptomatic diabetic patients, while LV dilatation, systolic dysfunction or hypokinesia was seen in&amp;lt;10%. The main predictors of LV abnormalities were microalbuminuria and silent CAD. The presence of LV hypertrophy with another abnormality should raise the possibility of the presence of silent CAD.
    PMID: 21398163 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4604579</comments>
            <pubDate>Fri, 11 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4604579</guid>        </item>
        <item>
            <title>Association of the metabolic syndrome with physical activity performance in patients with schizophrenia.</title>
            <link>http://www.medworm.com/index.php?rid=4604580&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21393044%26dopt%3DAbstract</link>
            <description>CONCLUSION: MetS is associated with poorer PA performance in patients with schizophrenia. The additional burden of MetS places patients with schizophrenia at even greater risk for physical and functional limitations in daily life.
    PMID: 21393044 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4604580</comments>
            <pubDate>Tue, 08 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4604580</guid>        </item>
        <item>
            <title>Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health checkups.</title>
            <link>http://www.medworm.com/index.php?rid=4604581&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21377910%26dopt%3DAbstract</link>
            <description>CONCLUSION: Elevated serum uric acid predicted IFG and T2DM only in Japanese women undergoing regular health checkups.
    PMID: 21377910 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4604581</comments>
            <pubDate>Fri, 04 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4604581</guid>        </item>
        <item>
            <title>TLR4 and RAGE: Similar routes leading to inflammation in type 2 diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=4604582&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21377387%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our results clearly show an exacerbation of innate immunity in PBMNC with T2D that was possibly hyperglycaemia-induced. These data, when analyzed together, suggest the importance of innate immunity in the pathogenesis of T2D.
    PMID: 21377387 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4604582</comments>
            <pubDate>Thu, 03 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4604582</guid>        </item>
        <item>
            <title>Direct effects of rapid-acting insulin analogues on insulin signaling in human pancreatic islets in vitro.</title>
            <link>http://www.medworm.com/index.php?rid=4542035&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21354844%26dopt%3DAbstract</link>
            <description>CONCLUSION: Insulin analogues have differential effects on the expression of insulin-signaling molecules in human pancreatic islets that are also dependent on the degree of glucose exposure.
    PMID: 21354844 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4542035</comments>
            <pubDate>Fri, 25 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4542035</guid>        </item>
        <item>
            <title>Evaluation of the moisturizer Pédimed(®) in the foot care of diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=4542036&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21349756%26dopt%3DAbstract</link>
            <description>CONCLUSION: Validated clinical and paraclinical tools demonstrated the efficacy of Pédimed(®) in improving xerosis and reducing fissures of the feet in diabetic patients.
    PMID: 21349756 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4542036</comments>
            <pubDate>Tue, 22 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4542036</guid>        </item>
        <item>
            <title>Vitamin D and type 2 diabetes mellitus: Where do we stand?</title>
            <link>http://www.medworm.com/index.php?rid=4542037&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21345709%26dopt%3DAbstract</link>
            <description>CONCLUSION: Although more studies are needed to confirm the role of VTD in the treatment of T2DM, there is nevertheless enough evidence at this time to suggest a need to maintain 25-OH vitamin D levels in T2DM patients around 30ng/mL over the course of a year.
    PMID: 21345709 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4542037</comments>
            <pubDate>Mon, 21 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4542037</guid>        </item>
        <item>
            <title>Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review.</title>
            <link>http://www.medworm.com/index.php?rid=4542038&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21333580%26dopt%3DAbstract</link>
            <description>CONCLUSION: Analyses based on a systematic review showed that treatment with IAsp in T1DM patients resulted in moderately better metabolic control and treatment satisfaction than RHI. In T2DM patients, meta-analysis showed improvement in PPG, but not in any other outcomes.
    PMID: 21333580 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4542038</comments>
            <pubDate>Wed, 16 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4542038</guid>        </item>
        <item>
            <title>Outcome in AN adult patients: A 13-year follow-up in 484 patients.</title>
            <link>http://www.medworm.com/index.php?rid=4485047&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21317006%26dopt%3DAbstract</link>
            <description>Authors: Rigaud D, Pennacchio H, Bizeul C, Reveillard V, Vergès B
    BACKGROUND: To study the long-term prognosis of anorexia nervosa (AN), 484 adult AN patients were followed on a mean duration of 13 years. RESULTS: The mortality rate was 1.2%. Eight factors were linked to the lack of recovery at 2 years: low BMI at discharge, low energy and fat intakes, high drive for excessive exercising, high score for perfectionism, for interpersonal distrust and for anxiety, use of tube-feeding and adhesion to treatment (P&amp;lt;0.02). Four factors explained the risk of the binge/purging form at 2 years: having had binge-eating disorder and overweight before AN, having had purging episodes within the first 2 years of AN; having had very high energy intakes through meals and being not treated by t...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4485047</comments>
            <pubDate>Fri, 11 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4485047</guid>        </item>
        <item>
            <title>Intensifying glycaemic control with insulin reduces adiponectin and its HMW isoform moderately in type 2, but not in type 1, diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4485048&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21306933%26dopt%3DAbstract</link>
            <description>CONCLUSION: Glycaemic control with insulin reduces ADPN in T2D patients in the short-term, but was ineffective in T1D.
    PMID: 21306933 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4485048</comments>
            <pubDate>Mon, 07 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4485048</guid>        </item>
        <item>
            <title>New-onset diabetes after transplantation: Risk factors and clinical impact.</title>
            <link>http://www.medworm.com/index.php?rid=4485049&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21295510%26dopt%3DAbstract</link>
            <description>Authors: Räkel A, Karelis AD
    With improvements in patient and graft survival, increasing attention has been placed on complications that contribute to long-term patient morbidity and mortality. New-onset diabetes after transplantation (NODAT) is a common complication of solid-organ transplantation, and is a strong predictor of graft failure and cardiovascular mortality in the transplant population. Risk factors for NODAT in transplant recipients are similar to those in non-transplant patients, but transplant-specific risk factors such as hepatitis C (HCV) infection, corticosteroids and calcineurin inhibitors play a dominant role in NODAT pathogenesis. Management of NODAT is similar to type 2 diabetes management in the general population. However, adjusting the immunosuppressant regime...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4485049</comments>
            <pubDate>Wed, 02 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4485049</guid>        </item>
        <item>
            <title>Arterial hypertension in overweight and obese algerian adolescents: Role of abdominal adiposity.</title>
            <link>http://www.medworm.com/index.php?rid=4485050&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21277245%26dopt%3DAbstract</link>
            <description>CONCLUSION: The prevalence of hypertension is high in overweight and obese adolescents, and higher in boys than in girls. Hypertension and arterial stiffness, as determined by high PP levels, were associated with abdominal adiposity. It is recommended that prehypertension be identified in overweight adolescents and that lifestyle changes be made to avoid its evolution towards obesity and hypertension.
    PMID: 21277245 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4485050</comments>
            <pubDate>Thu, 27 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4485050</guid>        </item>
        <item>
            <title>The prevalence, characteristics and metabolic consequences of renal insufficiency in very old hospitalized diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=4417807&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21273106%26dopt%3DAbstract</link>
            <description>CONCLUSION: Renal insufficiency often occurs without albuminuria, suggesting aetiologies distinct from classical diabetic nephropathy, and is strongly associated with vascular comorbidities. Hypoalbuminaemia is more strongly associated with inflammation than with albuminuria and malnutrition. Malnutrition, hypoalbuminaemia, low cholesterol levels and anaemia are not associated with renal insufficiency, likely due to the very high prevalence of these abnormalities in the whole population. These features must be taken into account when organizing the global care of elderly diabetic patients.
    PMID: 21273106 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417807</comments>
            <pubDate>Tue, 25 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4417807</guid>        </item>
        <item>
            <title>Exposure in utero to maternal diabetes leads to glucose intolerance and high blood pressure with no major effects on lipid metabolism.</title>
            <link>http://www.medworm.com/index.php?rid=4417808&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21257329%26dopt%3DAbstract</link>
            <description>CONCLUSION: Altogether, these results show that our model of exposure in utero to maternal diabetes led to normal birth weights, and induced transient glucose intolerance and increased blood pressure with no major effects on lipid metabolism. It also suggests that a hyperglycaemic fetal environment may be able to 'programme' hypertension and glucose intolerance, but not alter lipid metabolism.
    PMID: 21257329 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417808</comments>
            <pubDate>Fri, 21 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4417808</guid>        </item>
        <item>
            <title>Changes in body composition during weight loss in obese subjects in the NUGENOB study: Comparison of bioelectrical impedance vs. dual-energy X-ray absorptiometry.</title>
            <link>http://www.medworm.com/index.php?rid=4417811&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21236715%26dopt%3DAbstract</link>
            <description>CONCLUSION: During moderate diet-induced weight loss, the use of BIA leads to estimates of changes in body composition at the individual level that can differ substantially from those assessed by DXA, indicating that BIA and DXA cannot be used interchangeably. However, BIA in this context may be used for assessing changes in body composition at group level.
    PMID: 21236715 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417811</comments>
            <pubDate>Wed, 12 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4417811</guid>        </item>
        <item>
            <title>Diabetes in Mozambique: Prevalence, management and healthcare challenges.</title>
            <link>http://www.medworm.com/index.php?rid=4417810&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21236716%26dopt%3DAbstract</link>
            <description>CONCLUSION: Diabetes prevalence is low in Mozambique, but most diabetic patients were neither aware of their condition nor being treated pharmacologically, thus posing serious challenges to the provision of adequate care in an already disadvantageous context.
    PMID: 21236716 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417810</comments>
            <pubDate>Wed, 12 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4417810</guid>        </item>
        <item>
            <title>Metformin and digestive disorders.</title>
            <link>http://www.medworm.com/index.php?rid=4417809&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21236717%26dopt%3DAbstract</link>
            <description>Authors: Bouchoucha M, Uzzan B, Cohen R
    Digestive disorders (diarrhoea, vomiting) represent the most common metformin side-effects (around 30%) with this first-line drug treatment for type 2 diabetes. In healthy individuals, metformin affects glucose, vitamin B12 and the digestive uptake of bile salts. In the colon, it acts locally by modifying glucose cell metabolism. Different pathophysiological hypotheses have been proposed to explain the metformin-induced diarrhoea and vomiting, which can sometimes cause the patient to stop an effective treatment. These theories include stimulation of intestinal secretion of serotonin, changes in incretin and glucose metabolism, and bile-salt malabsorption. However, none of these hypotheses can be considered an adequate pathophysiological explanati...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4417809</comments>
            <pubDate>Wed, 12 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4417809</guid>        </item>
        <item>
            <title>Prevalence and risk factors of diabetes in a community-based study in North India: The Chandigarh Urban Diabetes Study (CUDS).</title>
            <link>http://www.medworm.com/index.php?rid=4355397&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21195002%26dopt%3DAbstract</link>
            <description>CONCLUSION: The age-standardized prevalence of diabetes and prediabetes were 11.1% and 13.2%, respectively. Older age, family history of diabetes, obesity and hypertension were positively related, while educational status was negatively related, to the presence of diabetes.
    PMID: 21195002 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355397</comments>
            <pubDate>Wed, 29 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355397</guid>        </item>
        <item>
            <title>Ethnic differences in weight gain and diabetes risk: The Multiethnic Cohort Study.</title>
            <link>http://www.medworm.com/index.php?rid=4355398&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21193341%26dopt%3DAbstract</link>
            <description>CONCLUSION: These findings support the current public-health recommendations for weight control and particularly among ethnic groups at high risk for diabetes.
    PMID: 21193341 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355398</comments>
            <pubDate>Tue, 28 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355398</guid>        </item>
        <item>
            <title>Prevalence of type 2 diabetes and other cardiovascular risk factors in Mayotte in 2008: The MAYDIA study.</title>
            <link>http://www.medworm.com/index.php?rid=4355399&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21190885%26dopt%3DAbstract</link>
            <description>CONCLUSION: The high prevalence of obesity combined with a high prevalence of diabetes indicates a potential for further increases in the prevalence of diabetes and cardiovascular disease in Mayotte. Preventative action against obesity, diabetes and hypertension is required now, as well as plans for appropriate healthcare delivery in the island.
    PMID: 21190885 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355399</comments>
            <pubDate>Mon, 27 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355399</guid>        </item>
        <item>
            <title>Brain lipid sensing and nervous control of energy balance.</title>
            <link>http://www.medworm.com/index.php?rid=4355400&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21185213%26dopt%3DAbstract</link>
            <description>Authors: Migrenne S, Le Foll C, Levin BE, Magnan C
    Nutrient sensitive neurons (glucose and fatty acids (FA)) are present in many sites throughout the brain, including the hypothalamus and brainstem, and play a key role in the neural control of energy and glucose homeostasis. Through neuronal output, FA may modulate feeding behaviour as well as both insulin secretion and action. For example, central administration of oleate inhibits food intake and glucose production in rats. This suggests that daily variations in plasma FA concentrations might be detected by the central nervous system as a signal which contributes to the regulation of energy balance. At the cellular level, subpopulations of neurons in the ventromedial and arcuate hypothalamic nuclei are selectively either inhibited or ...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355400</comments>
            <pubDate>Wed, 22 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355400</guid>        </item>
        <item>
            <title>Management of patients hospitalized for diabetic foot infection: Results of the French OPIDIA study.</title>
            <link>http://www.medworm.com/index.php?rid=4355401&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21169044%26dopt%3DAbstract</link>
            <description>CONCLUSION: In spite of being managed at specialized centres that were, in general, following the agreed-upon published guidelines, the prognosis for diabetic foot infection remains poor, with a high rate (48%) of lower-limb amputation.
    PMID: 21169044 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355401</comments>
            <pubDate>Fri, 17 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355401</guid>        </item>
        <item>
            <title>Acute resistance exercise is more effective than aerobic exercise for 24h blood pressure control in type 2 diabetics.</title>
            <link>http://www.medworm.com/index.php?rid=4355402&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21159536%26dopt%3DAbstract</link>
            <description>CONCLUSION: A single exercise bout decreases BP in T2D patients over a 24h period, with RES being more effective than AER exercise for BP control.
    PMID: 21159536 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355402</comments>
            <pubDate>Mon, 13 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355402</guid>        </item>
        <item>
            <title>Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: From one crisis to another.</title>
            <link>http://www.medworm.com/index.php?rid=4355404&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21147013%26dopt%3DAbstract</link>
            <description>CONCLUSION: In patients at risk of G6PD deficiency, the possibility of haemolysis should be explored in case of diabetes crisis. In African patients with KPT2D diabetes, potentially oxidative hypoglycaemic agents should be avoided in the remission phase of the disease. G6PD deficiency and diabetes can aggravate each other, and diabetes could be aetiologically associated with G6PD deficiency.
    PMID: 21147013 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355404</comments>
            <pubDate>Fri, 10 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355404</guid>        </item>
        <item>
            <title>Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001.</title>
            <link>http://www.medworm.com/index.php?rid=4355403&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21147014%26dopt%3DAbstract</link>
            <description>CONCLUSION: The number of centres using insulin pump therapy for diabetic children and the number of children treated by insulin pump were increased fourfold and 10-fold, respectively, from 2001 to 2007, indicating greater access to pump therapy in the French paediatric population. The present survey is still ongoing to evaluate the decision-making criteria that influence the initiation of insulin pump therapy in T1D paediatric patients.
    PMID: 21147014 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355403</comments>
            <pubDate>Fri, 10 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355403</guid>        </item>
        <item>
            <title>RETIDIAB(®): Assessment of a continuing medical education website for the improvement of diabetic retinopathy management.</title>
            <link>http://www.medworm.com/index.php?rid=4355406&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21145772%26dopt%3DAbstract</link>
            <description>CONCLUSION: This pilot study demonstrated the value and effectiveness of RETIDIAB(®), a new CME website exclusively devoted to DR management.
    PMID: 21145772 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355406</comments>
            <pubDate>Wed, 08 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355406</guid>        </item>
        <item>
            <title>Association of endothelial lipase Thr111Ile polymorphism with lipid metabolism and microvascular complications in type 2 diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=4355405&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21145773%26dopt%3DAbstract</link>
            <description>CONCLUSION: The c.584C&amp;gt;T EL polymorphism is associated with a higher risk of diabetic retinopathy that could be linked to modifications in HDL-cholesterol metabolism and blood pressure levels.
    PMID: 21145773 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355405</comments>
            <pubDate>Wed, 08 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355405</guid>        </item>
        <item>
            <title>Statin therapy and cataract in Type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4355407&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21145274%26dopt%3DAbstract</link>
            <description>CONCLUSION: In this cross-sectional analysis of a large diabetic population at very high risk of both DR and cataract, chronic therapy with statins was not cataractogenic, and the presence of cataract was not associated with more statin or other lipid-lowering drug use. This suggests that the benefits of statin therapy in T2D may far outweigh any potential ocular drawbacks as a side effect which, in any case, were not supported by our findings.
    PMID: 21145274 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355407</comments>
            <pubDate>Tue, 07 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355407</guid>        </item>
        <item>
            <title>Structural modifications in the arterial wall during physiological aging and as a result of diabetes mellitus in a mouse model: Are the changes comparable?</title>
            <link>http://www.medworm.com/index.php?rid=4355410&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21144786%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our study compared EDR linked to physiological aging with that observed in the case of STZ-induced diabetes over a short-term period, and demonstrated the beneficial effect of AG.
    PMID: 21144786 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355410</comments>
            <pubDate>Mon, 06 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355410</guid>        </item>
        <item>
            <title>Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.</title>
            <link>http://www.medworm.com/index.php?rid=4355409&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21144787%26dopt%3DAbstract</link>
            <description>CONCLUSION: The FINDRISC questionnaire performed well as a screening tool for the cross-sectional detection of unknown diabetes, IFG, IGT and the MetS in the Greek population.
    PMID: 21144787 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355409</comments>
            <pubDate>Mon, 06 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355409</guid>        </item>
        <item>
            <title>Are serum α- and β-carotene concentrations associated with the development of advanced beta-cell autoimmunity in children with increased genetic susceptibility to type 1 diabetes?</title>
            <link>http://www.medworm.com/index.php?rid=4355408&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21144788%26dopt%3DAbstract</link>
            <description>CONCLUSION: The present study data provided no clear evidence to support an association between serum α- or β-carotene concentration and advanced beta-cell autoimmunity.
    PMID: 21144788 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355408</comments>
            <pubDate>Mon, 06 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4355408</guid>        </item>
        <item>
            <title>Effect of atorvastatin on lipoprotein (a) and interleukin-10: A randomized placebo-controlled trial.</title>
            <link>http://www.medworm.com/index.php?rid=4258553&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21131223%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our results suggest that 12-week atorvastatin is effective in reducing Lp(a) in dyslipidaemic patients free of CVD. Furthermore, this is also the first evidence that the drug increases IL-10 in a dose-dependent manner.
    PMID: 21131223 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4258553</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4258553</guid>        </item>
        <item>
            <title>Poor prognosis of pregnancy in women with autoimmune type 1 diabetes mellitus masquerading as gestational diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4258557&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21126899%26dopt%3DAbstract</link>
            <description>CONCLUSION: T1D may reveal as GDM in women with or without risk factors for GDM and is associated with a poor prognosis, partly because the correct diagnosis and treatment are delayed. Whether screening for autoimmune markers of T1D should be performed more systematically in women with GDM deserves to be studied.
    PMID: 21126899 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4258557</comments>
            <pubDate>Tue, 30 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4258557</guid>        </item>
        <item>
            <title>Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method?</title>
            <link>http://www.medworm.com/index.php?rid=4258556&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21126900%26dopt%3DAbstract</link>
            <description>CONCLUSION: While fasting-based indices of IS are a suitable option for large cohorts, OGTT-derived indices may represent a useful compromise for obtaining both clinical (glucose tolerance) and physiological (insulin sensitivity) information, making them particularly useful for large-scale physiological and epidemiological studies.
    PMID: 21126900 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4258556</comments>
            <pubDate>Tue, 30 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4258556</guid>        </item>
        <item>
            <title>Adiponectin and leptin in Afro-Caribbean men and women with HIV infection: Association with insulin resistance and type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4258555&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21126901%26dopt%3DAbstract</link>
            <description>CONCLUSION: Insulin resistance is frequent in Afro-Caribbean women with HIV infection. Overweight and obesity are major risk factors in such a population. Systematic screening for insulin resistance should be carried out in this population, which has a high prevalence of T2D.
    PMID: 21126901 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4258555</comments>
            <pubDate>Tue, 30 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4258555</guid>        </item>
        <item>
            <title>Lipids, lipid-lowering therapy and diabetes complications.</title>
            <link>http://www.medworm.com/index.php?rid=4258554&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21126902%26dopt%3DAbstract</link>
            <description>Authors: Valensi P, Picard S
    Cardiovascular disease (CVD) remains the primary cause of morbidity and mortality in patients with diabetes. Lipid-lowering therapy (LLT) is often required, and statin drugs are usually the first-line therapy. However, even when LDL-cholesterol values are within the target range, a substantial residual risk persists. Fibrates may help to lower this risk, especially in patients with high triglyceride and low HDL-cholesterol levels, as suggested by the lipid ACCORD trial. Furthermore, they may even have beneficial effects on the development of microvascular complications such as nephropathy and especially retinopathy, as suggested by the results of the FIELD study. Data suggest benefit with fenofibrate on diabetic retinopathy, with significant effects on the ...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4258554</comments>
            <pubDate>Tue, 30 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4258554</guid>        </item>
        <item>
            <title>Anthropometric characteristics and cardiometabolic risk factors in a sample of urban-dwelling adults in Senegal.</title>
            <link>http://www.medworm.com/index.php?rid=4224355&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21112227%26dopt%3DAbstract</link>
            <description>CONCLUSION: Obesity still appears to be rare in Senegalese urban-dwelling men, whereas women, despite their overweight, have no untoward cardiometabolic profiles. However, the observed correlations between cardiometabolic risk factors and the amount and/or distribution of body fat suggest that obesity prevention should not be overlooked in the public health agenda for sub-Saharan Africa.
    PMID: 21112227 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4224355</comments>
            <pubDate>Thu, 25 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4224355</guid>        </item>
        <item>
            <title>Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus.</title>
            <link>http://www.medworm.com/index.php?rid=4205613&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21109476%26dopt%3DAbstract</link>
            <description>CONCLUSION: Serum RBP4 levels are significantly increased in pregnancy, independent of age and BMI, and are also considerably higher in pregnant women with GDM than in those with normal glucose tolerance. In addition, serum RBP4 levels appear to be a valuable marker of insulin resistance and dysfunctional lipid metabolism in pregnancy.
    PMID: 21109476 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4205613</comments>
            <pubDate>Tue, 23 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4205613</guid>        </item>
        <item>
            <title>GLP-1: What is known, new and controversial in 2010?</title>
            <link>http://www.medworm.com/index.php?rid=4173015&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21075654%26dopt%3DAbstract</link>
            <description>Authors: Burcelin R, Dejager S
    Over the past 2years, more than 1300 manuscripts have been published on glucagon-like peptide-1 (GLP-1) and yet, what do we know about it for sure? The European Club for the Study of GLP-1 (EuCSGLP-1) has debated the latest controversies concerning GLP-1, including both fundamental and clinical aspects, and concluded that the control of glucose metabolism by GLP-1 requires paracrine activation of the enteric nervous system to regulate numerous physiological functions. This involves-but is not limited to-the endocrine pancreas, liver, cardiovascular system, gastric-emptying and the brain. For this reason, the role of GLP-1 as an endocrine hormone has come under question. As systemic concentration of the peptide was not thought to be relevant to its physiol...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4173015</comments>
            <pubDate>Fri, 12 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4173015</guid>        </item>
        <item>
            <title>O-GlcNAc modification, insulin signaling and diabetic complications.</title>
            <link>http://www.medworm.com/index.php?rid=4173016&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21074472%26dopt%3DAbstract</link>
            <description>Authors: Issad T, Masson E, Pagesy P
    O-GlcNAc glycosylation (O-GlcNAcylation) corresponds to the addition of N-acetylglucosamine on serine and threonine residues of cytosolic and nuclear proteins. O-GlcNAcylation is a dynamic post-translational modification, analogous to phosphorylation, that regulates the stability, the activity or the subcellular localisation of target proteins. This reversible modification depends on the availability of glucose and therefore constitutes a powerful mechanism by which cellular activities are regulated according to the nutritional environment of the cell. O-GlcNAcylation has been implicated in important human pathologies including Alzheimer disease and type-2 diabetes. Only two enzymes, OGT and O-GlcNAcase, control the O-GlcNAc level on proteins. There...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4173016</comments>
            <pubDate>Wed, 10 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4173016</guid>        </item>
        <item>
            <title>Information and therapeutic education of diabetic patients in French hospitals: The OBSIDIA survey.</title>
            <link>http://www.medworm.com/index.php?rid=4158456&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21055993%26dopt%3DAbstract</link>
            <description>CONCLUSION: TE is well implemented in French hospitals, but lacks homogeneity and standardization. Training is inadequate from both qualitative and quantitative points of view, and evaluation of TE procedures needs to be developed. There is also a need for more funding and dedicated qualified staff, a lack of which is partly due to the fact that TE is not a recognized medical activity in hospitals.
    PMID: 21055993 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4158456</comments>
            <pubDate>Wed, 03 Nov 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4158456</guid>        </item>
        <item>
            <title>Prevalence of treated diabetes: Geographical variations at the small-area level and their association with area-level characteristics. A multilevel analysis in Southeastern France.</title>
            <link>http://www.medworm.com/index.php?rid=4109108&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20980182%26dopt%3DAbstract</link>
            <description>CONCLUSION: This study found a positive association between area deprivation and TD, and adds further evidence to the scanty data so far available on this topic. This finding should contribute to pinpointing priority action areas for programmes of diabetes prevention. However, more research is needed to further elucidate the mechanism(s) linking area deprivation and diabetes.
    PMID: 20980182 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4109108</comments>
            <pubDate>Sun, 24 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4109108</guid>        </item>
        <item>
            <title>Waist circumference and mortality: Impact of associated risk factors.</title>
            <link>http://www.medworm.com/index.php?rid=4098800&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20951621%26dopt%3DAbstract</link>
            <description>CONCLUSION: In a population with low-to-moderate mortality risk, waist circumference alone did not identify high-risk subjects, thus suggesting that a more global approach is necessary.
    PMID: 20951621 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4098800</comments>
            <pubDate>Wed, 13 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4098800</guid>        </item>
        <item>
            <title>How patients' attitudes and opinions influence self-care behaviours in type 2 diabetes. Insights from the French DIABASIS Survey.</title>
            <link>http://www.medworm.com/index.php?rid=4098801&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20947405%26dopt%3DAbstract</link>
            <description>CONCLUSION: The DIABASIS survey provides important information for diabetes care by identifying distinct patients' profiles that express different degrees of difficulty in implementing self-management. For this reason, patients in each category require different kinds of customized support from their physician to induce behavioural changes that may be key in improving their metabolic control.
    PMID: 20947405 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4098801</comments>
            <pubDate>Mon, 11 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4098801</guid>        </item>
        <item>
            <title>HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005).</title>
            <link>http://www.medworm.com/index.php?rid=4066906&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20934897%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our study indicates that HbA(1c) is strongly predictive of new-onset diabetes in this northern Spanish population, and was similar to FPG and 2hPG in predictive capability. Also, the combined measurement of FPG and HbA(1c) improved their individual predictive performance.
    PMID: 20934897 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4066906</comments>
            <pubDate>Thu, 07 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4066906</guid>        </item>
        <item>
            <title>Therapeutic alliance and glycaemic control in type 1 diabetes: A pilot study.</title>
            <link>http://www.medworm.com/index.php?rid=4066907&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20934364%26dopt%3DAbstract</link>
            <description>CONCLUSION: Although the observational nature of the present study prevents causal conclusions to be drawn, these preliminary results suggest that promoting therapeutic alliance can improve glycaemic control in type 1 diabetes.
    PMID: 20934364 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4066907</comments>
            <pubDate>Wed, 06 Oct 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4066907</guid>        </item>
        <item>
            <title>Long-term animal-protein consumption is associated with an increased prevalence of diabetes among the elderly: The Mediterranean islands (MEDIS) study.</title>
            <link>http://www.medworm.com/index.php?rid=4030894&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20888279%26dopt%3DAbstract</link>
            <description>CONCLUSION: Animal-protein consumption was associated with a higher prevalence of diabetes among the elderly, whereas protein intakes, especially from plant sources, within the recommended range appear to confer considerable protection. This suggests that reducing or controlling the burden of diabetes through dietary means in the elderly should include monitoring their daily protein intake.
    PMID: 20888279 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4030894</comments>
            <pubDate>Tue, 28 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4030894</guid>        </item>
        <item>
            <title>Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=4030893&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20888280%26dopt%3DAbstract</link>
            <description>Authors: Reznik Y
    Continuous subcutaneous insulin infusion (CSII) using an external pump is widely used for the treatment of type 1 diabetes, but has been less evaluated in type 2 diabetes. This review analyzes the open-label as well as randomized controlled studies performed in type 2 diabetic patients. The efficacy of CSII is compared with multiple daily injections (MDI) in terms of glycaemic control, weight variation, insulin requirements, treatment satisfaction and hypoglycaemic events. CSII may be offered as an alternative treatment to type 2 diabetic patients with poor glycaemic control despite high-dose insulin requirements administered through MDI.
    PMID: 20888280 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4030893</comments>
            <pubDate>Tue, 28 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4030893</guid>        </item>
        <item>
            <title>A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=3965957&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20832344%26dopt%3DAbstract</link>
            <description>CONCLUSION: Rates of SMI and significant CAD in asymptomatic high-risk type 2 diabetic patients receiving intensive care of risk factors are low, and SPECT and DE are similar in the detection of SMI and CAD. Coronary revascularization and intensive CV risk-factor therapy are associated with a low rate of adverse CV events at 3years, whichever stress test was used.
    PMID: 20832344 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3965957</comments>
            <pubDate>Tue, 07 Sep 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3965957</guid>        </item>
        <item>
            <title>A new simple method for assessing sudomotor function: Relevance in type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3913409&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20739207%26dopt%3DAbstract</link>
            <description>CONCLUSION: The good sensitivity, specificity and reproducibility of EZSCAN make it a feasible alternative for assessing sudomotor dysfunction, a clinical manifestation of autonomic neuropathy in diabetic patients. The test takes&amp;lt;3min to perform, and requires neither special patient preparation nor medical personnel training.
    PMID: 20739207 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3913409</comments>
            <pubDate>Sun, 22 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3913409</guid>        </item>
        <item>
            <title>Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=3913408&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20739208%26dopt%3DAbstract</link>
            <description>CONCLUSION: These results suggest that variations in resistin concentrations are not directly related to susceptibility to type 2 diabetes. However, it may be that resistin plays a role in the pathogenesis of obesity and insulin resistance, both of which could, indirectly, contribute to the development of type 2 diabetes.
    PMID: 20739208 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3913408</comments>
            <pubDate>Sun, 22 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3913408</guid>        </item>
        <item>
            <title>The metabolic syndrome defined by modified International Diabetes Federation criteria and mortality: A 9-year follow-up of the aged in Finland.</title>
            <link>http://www.medworm.com/index.php?rid=3876027&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20708423%26dopt%3DAbstract</link>
            <description>CONCLUSION: These findings suggest that MetS does not predict mortality later in life and, of the separate components of MetS, only low HDL cholesterol is predictive of mortality in women. Also, even markedly higher blood pressure values than those included in the criteria for MetS fail to predict mortality in this age group.
    PMID: 20708423 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3876027</comments>
            <pubDate>Tue, 10 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3876027</guid>        </item>
        <item>
            <title>Vitamin D and diabetes: Much ado about nothing?</title>
            <link>http://www.medworm.com/index.php?rid=3845499&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20688551%26dopt%3DAbstract</link>
            <description>Authors: Monnier L, Colette C
    
    PMID: 20688551 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3845499</comments>
            <pubDate>Mon, 02 Aug 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3845499</guid>        </item>
        <item>
            <title>Physical exercise for the prevention and treatment of type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3813908&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20675173%26dopt%3DAbstract</link>
            <description>The objectives of this review are to assess the effects of exercise on the prevention of type 2 diabetes in high-risk individuals and on glycaemic control in type 2 diabetic patients. Considering the available reports, there is unequivocal and strong evidence that physical exercise can prevent or delay progression to type 2 diabetes in subjects with impaired glucose tolerance. Also, lifestyle interventions, including diet and physical exercise, can result in a reduction of around 50% in diabetes incidence that persists even after the individual lifestyle counselling has stopped. In addition, short-term randomized studies have confirmed that physical training based on endurance and/or resistance exercises can also improve blood glucose control in type 2 diabetics with a mean glycated haemog...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3813908</comments>
            <pubDate>Thu, 29 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3813908</guid>        </item>
        <item>
            <title>The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study.</title>
            <link>http://www.medworm.com/index.php?rid=3813909&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20673644%26dopt%3DAbstract</link>
            <description>CONCLUSION: Irrespective of definition, MetS is a significant predictor of incident CVD events and incident diabetes. Also, the new Harmonization definition may be a better predictor of incident CVD than the sum of its components.
    PMID: 20673644 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3813909</comments>
            <pubDate>Mon, 26 Jul 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3813909</guid>        </item>
        <item>
            <title>Effect of type 2 diabetes on plasma kallikrein activity after physical exercise and its relationship to post-exercise hypotension.</title>
            <link>http://www.medworm.com/index.php?rid=3714489&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20579916%26dopt%3DAbstract</link>
            <description>CONCLUSION: T2D individuals have a lower PKA response to exercise, which probably suppresses its hypotensive effect, thus reinforcing the possible role of PKA on PEH.
    PMID: 20579916 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3714489</comments>
            <pubDate>Tue, 22 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3714489</guid>        </item>
        <item>
            <title>Decreasing postprandial C-peptide levels over time are not associated with long-term use of sulphonylurea: An observational study.</title>
            <link>http://www.medworm.com/index.php?rid=3714488&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20579917%26dopt%3DAbstract</link>
            <description>CONCLUSION: Both HbA(1c) and beta-cell function decreased over 10 years with SU treatment, but such treatment was not associated with a pronounced decline in beta-cell function. These results, however, need to be interpreted with caution, as this was an observational study. Nevertheless, the present study findings do not support the notion that SU, as used in clinical practice, is harmful to beta-cell function.
    PMID: 20579917 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3714488</comments>
            <pubDate>Tue, 22 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3714488</guid>        </item>
        <item>
            <title>Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity.</title>
            <link>http://www.medworm.com/index.php?rid=3684530&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20561808%26dopt%3DAbstract</link>
            <description>Authors: Delaere F, Magnan C, Mithieux G
    Glycolysis is an essential metabolic function that lies at the core of any cellular life. Glucose homoeostasis is, thus, a crucial physiological function of living organisms. A system of plasma glucose-sensing in the portal vein plays a key role in this homoeostasis. Connected to the hypothalamus via the peripheral nervous system, the system allows the body to adapt its response to any variation of portal glycaemia. The hypothalamus controls food intake (exogenous glucose supply) and hepatic glycogenolysis (endogenous glucose supply). Intestinal gluconeogenesis, via the release of glucose into the portal vein, plays a key role in the control of hunger and satiety, and of endogenous glucose production through the modulation of liver insulin sensi...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3684530</comments>
            <pubDate>Wed, 16 Jun 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3684530</guid>        </item>
        <item>
            <title>Diabetes mellitus, hyperglycaemia and cancer.</title>
            <link>http://www.medworm.com/index.php?rid=3677655&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20554237%26dopt%3DAbstract</link>
            <description>Authors: Simon D, Balkau B
    A moderate increase in cancer risk has been shown in diabetic patients and in individuals with abnormal glucose tolerance, mainly for digestive sites, independently of obesity, with in contrast, a protective effect for prostate cancer. Insulin-resistance with compensatory hyperinsulinemia, and elevated levels of circulating growth factors are usually considered to be the link between cancer and hyperglycaemia, through activated cell proliferation. Treatments inducing elevated plasma insulin seem to increase cancer risk but insulin-sensitizers (metformine, thiazolidinediones) seem to reduce cancer risk. In 2009, there was a controversy on the specific action of glargine insulin to increase cancer risk, from an observational study in Germany, which accumulated ...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3677655</comments>
            <pubDate>Mon, 31 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3677655</guid>        </item>
        <item>
            <title>Discordance between non-HDL cholesterol and LDL cholesterol levels in patients with diabetes without previous cardiovascular events.</title>
            <link>http://www.medworm.com/index.php?rid=3656854&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20537932%26dopt%3DAbstract</link>
            <description>CONCLUSION: There was a significant discordance between LDL and non-HDL cholesterol levels in diabetes patients with high triglycerides or the MS. This might explain patients' high residual CV risk despite having achieved their desirable LDL cholesterol levels. Thus, treating both non-HDL and LDL cholesterol to achieve target values should be considered to reduce residual CV risk in patients with diabetes.
    PMID: 20537932 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3656854</comments>
            <pubDate>Mon, 24 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3656854</guid>        </item>
        <item>
            <title>Self-perception of health status, mental health and quality of life among adults with diabetes residing in a metropolitan area.</title>
            <link>http://www.medworm.com/index.php?rid=3586497&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20483647%26dopt%3DAbstract</link>
            <description>CONCLUSION: Self-rated health and psychological well-being, and HRQL, are all considerably poorer among patients with diabetes vs those without diabetes. The poorest quality of life among those with diabetes associated with female gender, depression, lack of exercise and obesity.
    PMID: 20483647 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586497</comments>
            <pubDate>Sun, 16 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586497</guid>        </item>
        <item>
            <title>Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men.</title>
            <link>http://www.medworm.com/index.php?rid=3586496&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20483648%26dopt%3DAbstract</link>
            <description>CONCLUSION: Fat and fructose both increased IHCL, but fructose increased, while fat decreased, VLDL triacylglycerols. However, excess fat and fructose combined had additive effects on IHCL and neutralizing effects on VLDL triglycerides. This suggests that fructose stimulates, while fat inhibits, hepatic VLDL triacylglycerol secretion.
    PMID: 20483648 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3586496</comments>
            <pubDate>Sun, 16 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3586496</guid>        </item>
        <item>
            <title>Insulin resistance, diabetes and cognitive function: Consequences for preventative strategies.</title>
            <link>http://www.medworm.com/index.php?rid=3574157&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20472485%26dopt%3DAbstract</link>
            <description>Authors: Bourdel-Marchasson I, Lapre E, Laksir H, Puget E
    Cognitive decline and dementia both place a heavy burden on patients and their relatives, and any means of preventing such age-related changes are worthy of consideration. Those who have the metabolic syndrome with or without diabetes suffer more often from dysexecutive problems and slower psychomotor speed than do other patients. In epidemiological studies, diabetes has appeared to be a risk factor for all types of dementia, including vascular dementia, although the role of the metabolic syndrome in the risk of Alzheimer's disease is still a matter of debate. The possible mechanisms of cognitive alterations are multiple, and may differ according to age group and duration of diabetes or the metabolic syndrome. Drug interventiona...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3574157</comments>
            <pubDate>Thu, 13 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3574157</guid>        </item>
        <item>
            <title>Attempt to improve glucose control in type 2 diabetic patients by education about real-time glucose monitoring.</title>
            <link>http://www.medworm.com/index.php?rid=3551151&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20452799%26dopt%3DAbstract</link>
            <description>Authors: Thielen V, Scheen A, Bringer J, Renard E
    The effectiveness of a specific educational programme involving the use of a real-time glucose-sensor system (Guardian RT((R))) to improve glucose control was investigated in patients with poorly controlled type 2 diabetes despite insulin therapy. Ten patients participated in a randomized crossover study comparing two 3-month periods, during which glucose levels were monitored by either self-monitoring of blood glucose (SMBG) alone or by Guardian RT((R)) (restricted to 1 week per month) in addition to SMBG. Only four of the enrolled patients completed both periods, while dropouts were mainly due to technical difficulties in using the device. All six patients who completed the first 3-month period showed a reduction in glycated haemoglob...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3551151</comments>
            <pubDate>Thu, 06 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3551151</guid>        </item>
        <item>
            <title>Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity.</title>
            <link>http://www.medworm.com/index.php?rid=3547066&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20447851%26dopt%3DAbstract</link>
            <description>CONCLUSION: Exenatide significantly increased HOMA-B and hyperbolic product over a 6-month treatment period with no overall change in insulin sensitivity, despite weight loss. Thus, improved beta-cell function rather than increased insulin sensitivity accounts for the bulk of HbA(1c) reduction following 6months of exenatide treatment.
    PMID: 20447851 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3547066</comments>
            <pubDate>Mon, 03 May 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3547066</guid>        </item>
        <item>
            <title>Feasibility of screening for silent myocardial ischaemia according to the ALFEDIAM-SFC 2004 Guidelines in a population of diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=3534595&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20434384%26dopt%3DAbstract</link>
            <description>CONCLUSION: The number of examinations carried out in the region of Franche-ComtÃ© greatly exceeded the number of patients required for screening. However, practical feasibility is not the only criterion needed to guarantee the quality of a large-scale screening programme. Our results raise the question of the relevance of the current screening selection criteria.
    PMID: 20434384 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3534595</comments>
            <pubDate>Tue, 27 Apr 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3534595</guid>        </item>
        <item>
            <title>Are elderly patients with diabetes being overtreated in French long-term-care homes?</title>
            <link>http://www.medworm.com/index.php?rid=3444173&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20363171%26dopt%3DAbstract</link>
            <description>CONCLUSION: Our data show that, among older institutionalized patients, the prevalence of diabetes is high and the control of diabetes too tight, with a potential risk of hypoglycaemia. Antidiabetic treatment should be reduced when the HbA(1c) value is less than 7.5% in this frail and functionally dependent population. Furthermore, a diabetic diet, prescribed for more than half this population, is useless for glycaemic control and may even impinge on quality of life.
    PMID: 20363171 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3444173</comments>
            <pubDate>Wed, 31 Mar 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3444173</guid>        </item>
        <item>
            <title>Is it important to reduce inter- and intra-individual variations to explore insulin sensitivity?</title>
            <link>http://www.medworm.com/index.php?rid=3435629&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20359928%26dopt%3DAbstract</link>
            <description>Authors: Bastard JP, Antuna-Puente B, Rabasa-Lhoret R
    
    PMID: 20359928 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3435629</comments>
            <pubDate>Mon, 29 Mar 2010 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">3435629</guid>        </item>
        <item>
            <title>Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3421408&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20347376%26dopt%3DAbstract</link>
            <description>CONCLUSION: Many type 2 diabetic patients who begin treatment with an OAD will eventually be prescribed insulin. Age, disease severity and the type of prior treatment may affect the rate of the transition.
    PMID: 20347376 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3421408</comments>
            <pubDate>Thu, 25 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3421408</guid>        </item>
        <item>
            <title>Lipogenesis in arterial wall and vascular smooth muscle cells of Psammomys obesus: Its regulation and abnormalities in diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3395612&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20303812%26dopt%3DAbstract</link>
            <description>CONCLUSION: Lipogenesis is expressed in the arterial walls and VSMCs of P. obesus. However, its expression was not increased in diabetes, and did not respond to either T3 or angiotensin II. Therefore, lipogenesis in situ is unlikely to contribute to the accumulation of lipids in the arterial walls of diabetic P. obesus gerbils.
    PMID: 20303812 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3395612</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3395612</guid>        </item>
        <item>
            <title>Reproducibility of HOMA and QUICKI among individuals with variable glucose tolerance.</title>
            <link>http://www.medworm.com/index.php?rid=3395611&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20303813%26dopt%3DAbstract</link>
            <description>Authors: Borai A, Livingstone C, Farzal A, Kholeif M, Wang T, Ferns G
    
    PMID: 20303813 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3395611</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3395611</guid>        </item>
        <item>
            <title>Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy.</title>
            <link>http://www.medworm.com/index.php?rid=3395610&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20303814%26dopt%3DAbstract</link>
            <description>CONCLUSION: Frequency of sexual activity appears to be unaffected by pump therapy or diabetes, but is decreased by the expected characteristics-namely, age and being single. Also, only 10% of patients believe that CSII is an obstacle during sexual activity and, in particular, because of the catheter.
    PMID: 20303814 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3395610</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3395610</guid>        </item>
        <item>
            <title>Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3395609&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20303815%26dopt%3DAbstract</link>
            <description>CONCLUSION: When T2D patients were compared with non-diabetic subjects with similarly controlled levels of hyperglycaemia after oral glucose ingestion, they essentially differed only in peripheral glucose uptake, whereas endogenous glucose production was apparently unaltered.
    PMID: 20303815 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3395609</comments>
            <pubDate>Thu, 18 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3395609</guid>        </item>
        <item>
            <title>Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=3374977&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20226708%26dopt%3DAbstract</link>
            <description>CONCLUSION: To best assess peak postprandial glucose levels, the optimal time for blood glucose monitoring is about 1h and 15min after the start of the meal, albeit with wide interpatient variability. Nevertheless, 80% of post-meal blood glucose peaks were observed at less than 90min after the start of the meal.
    PMID: 20226708 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3374977</comments>
            <pubDate>Wed, 10 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3374977</guid>        </item>
        <item>
            <title>Evaluation of automated fundus photograph analysis algorithms for detecting microaneurysms, haemorrhages and exudates, and of a computer-assisted diagnostic system for grading diabetic retinopathy.</title>
            <link>http://www.medworm.com/index.php?rid=3358328&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20219404%26dopt%3DAbstract</link>
            <description>CONCLUSION: This study shows that previously published algorithms for computer-aided diagnosis is a reliable alternative to time-consuming manual analysis of fundus photographs when screening for DR. The use of this system would allow considerable timesavings for physicians and, therefore, alleviate the time spent on a mass-screening programme.
    PMID: 20219404 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3358328</comments>
            <pubDate>Mon, 08 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3358328</guid>        </item>
        <item>
            <title>Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men.</title>
            <link>http://www.medworm.com/index.php?rid=3338810&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20202879%26dopt%3DAbstract</link>
            <description>CONCLUSION: The combined use of low adiponectin levels and large WC measures has greater discriminative power than using either index alone to identify subjects at particular risk of glucose intolerance and clustering of risk factors.
    PMID: 20202879 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3338810</comments>
            <pubDate>Tue, 02 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3338810</guid>        </item>
        <item>
            <title>The metabolic syndrome: Prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis.</title>
            <link>http://www.medworm.com/index.php?rid=3338809&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20202880%26dopt%3DAbstract</link>
            <description>CONCLUSION: The prevalence of the MetS is markedly high within the population of Great Tunis and especially in women. As these findings predict future increases in cardiovascular disease in these populations, substantial efforts need to be made to fight against obesity and sedentary lifestyles to ameliorate the expected poor health outcomes.
    PMID: 20202880 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3338809</comments>
            <pubDate>Tue, 02 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3338809</guid>        </item>
        <item>
            <title>It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia.</title>
            <link>http://www.medworm.com/index.php?rid=3323255&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20189425%26dopt%3DAbstract</link>
            <description>The objectives of this review are to summarize the importance of screening for SMI in a subset of asymptomatic diabetic patients. There is evidence that screening markedly improves the evaluation of cardiovascular risk compared with the usual risk scores. New markers, validated by large-scale studies, are needed to help in identifying the patients with silent coronary stenoses, thereby lowering the number of screened patients. Some indications of benefit with revascularization in patients with silent coronary stenoses are also available. Although it is not yet time to stop screening diabetic patients for SMI, such screening should focus on patients who are at high or intermediate cardiovascular risk. Guidelines need to be updated to increase the value of screening.
    PMID: 20189425 [PubM...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3323255</comments>
            <pubDate>Thu, 25 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3323255</guid>        </item>
        <item>
            <title>Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3323256&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20188617%26dopt%3DAbstract</link>
            <description>CONCLUSION: Insulin glargine use throughout pregnancy does not appear to be associated with an increased rate of severe congenital malformations.
    PMID: 20188617 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3323256</comments>
            <pubDate>Wed, 24 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3323256</guid>        </item>
        <item>
            <title>Evaluation of the In2it((R)) analyzer for HbA(1c) determination.</title>
            <link>http://www.medworm.com/index.php?rid=3312782&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20181508%26dopt%3DAbstract</link>
            <description>CONCLUSION: The In2it((R)) analyzer is suitable for HbA(1c) assay in small laboratory series and for point-of-care testing, and its analytical performance is satisfactory overall. However, several issues related to software need to be improved for optimal application. Also, special attention should be paid concerning the possibility of underestimation of results in cases of high hypertriglyceridaemia.
    PMID: 20181508 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3312782</comments>
            <pubDate>Mon, 22 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3312782</guid>        </item>
        <item>
            <title>Age-related changes in insulin receptor mRNA and protein expression in genetically obese Zucker rats.</title>
            <link>http://www.medworm.com/index.php?rid=3270338&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20149705%26dopt%3DAbstract</link>
            <description>CONCLUSION: These data show that obese Zucker rats display age-related alterations of IR gene expression at both pre- and post-translational stages and, in particular, increased endocytosis and degradation of IR protein.
    PMID: 20149705 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3270338</comments>
            <pubDate>Tue, 09 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3270338</guid>        </item>
        <item>
            <title>Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.</title>
            <link>http://www.medworm.com/index.php?rid=3270337&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20149706%26dopt%3DAbstract</link>
            <description>CONCLUSION: Mostly self-controlled exercise of moderate intensity ameliorated serum levels of pro- and anti-atherogenic markers in patients with T2DM, with no effects on body weight. These data offer further insight into the cardioprotective mechanisms of exercise in patients with T2DM.
    PMID: 20149706 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3270337</comments>
            <pubDate>Mon, 08 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3270337</guid>        </item>
        <item>
            <title>Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy.</title>
            <link>http://www.medworm.com/index.php?rid=3258918&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20137994%26dopt%3DAbstract</link>
            <description>CONCLUSION: This study suggests an independent association between skin AF levels and diabetic nephropathy and neuropathy, but not retinopathy, in T1D patients. Prospective studies are needed to confirm the ability of skin AF levels to predict microangiopathy.
    PMID: 20137994 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3258918</comments>
            <pubDate>Thu, 04 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3258918</guid>        </item>
        <item>
            <title>Characteristics and management of diabetic patients hospitalized for myocardial infarction in France.</title>
            <link>http://www.medworm.com/index.php?rid=3232293&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20116316%26dopt%3DAbstract</link>
            <description>CONCLUSION: French diabetic patients subsequent to MI undergo fewer angioplasty procedures than do non-diabetic patients. After the acute stage, secondary preventative medications are used more often, with a marked rise in the use of insulin.
    PMID: 20116316 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3232293</comments>
            <pubDate>Wed, 27 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3232293</guid>        </item>
        <item>
            <title>How to improve screening for diabetic retinopathy: The Burgundy experience.</title>
            <link>http://www.medworm.com/index.php?rid=3232292&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20116317%26dopt%3DAbstract</link>
            <description>CONCLUSION: The DR screening campaign represents a major improvement in diabetic management, as around 80% of the screened patients with DR consulted an ophthalmologist after the screening campaign. However, the overall rate of diabetics having the recommended annual ophthalmological visit in the region of Burgundy remained unchanged.
    PMID: 20116317 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3232292</comments>
            <pubDate>Wed, 27 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3232292</guid>        </item>
        <item>
            <title>Blood glucose level on postoperative day 1 is predictive of adverse outcomes after cardiovascular surgery.</title>
            <link>http://www.medworm.com/index.php?rid=3221447&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20106702%26dopt%3DAbstract</link>
            <description>CONCLUSION: Glucose levels greater than 8.8mmol/L on postoperative day 1 and having three or more hypoglycaemic episodes in the postoperative period were predictive of mortality and morbidity among patients undergoing cardiovascular surgery. This suggests that a multidisciplinary approach may be able to achieve better postoperative blood glucose control.
    PMID: 20106702 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3221447</comments>
            <pubDate>Mon, 25 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3221447</guid>        </item>
        <item>
            <title>Efficacy and safety of an insulin infusion protocol during and after cardiac surgery.</title>
            <link>http://www.medworm.com/index.php?rid=3208815&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20097589%26dopt%3DAbstract</link>
            <description>CONCLUSION: This study showed that a BG target of 100-139mg/dL can be safely achieved with an insulin therapy protocol that can be routinely used in everyday clinical practice.
    PMID: 20097589 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3208815</comments>
            <pubDate>Fri, 22 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3208815</guid>        </item>
        <item>
            <title>Dietary cassava, beta-cell function and hyperbolic product loss rate in type 2 diabetes patients from South Kivu.</title>
            <link>http://www.medworm.com/index.php?rid=3208816&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20097112%26dopt%3DAbstract</link>
            <description>CONCLUSION: Cassava consumption in South Kivu is not associated with changes in T2D phenotype or in the glucose homoeostasis determinants S, B, BxS and BxS LR. Cassava consumption does not accelerate beta-cell function loss in such a population, whose markedly compromised glucose homoeostasis renders them vulnerable to environmentally acquired beta-cell impairment.
    PMID: 20097112 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3208816</comments>
            <pubDate>Thu, 21 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3208816</guid>        </item>
        <item>
            <title>Answer from author about &quot;Efficacity of periodontal treatment on glycaemic control in diabetic patients. A metaanalysis of interventional studies&quot;</title>
            <link>http://www.medworm.com/index.php?rid=3208817&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20096618%26dopt%3DAbstract</link>
            <description>Answer from author about &quot;Efficacity of periodontal treatment on glycaemic control in diabetic patients. A metaanalysis of interventional studies&quot;
    Diabetes Metab. 2010 Jan 20;
    Authors: Vergnes JN
    
    PMID: 20096618 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3208817</comments>
            <pubDate>Wed, 20 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3208817</guid>        </item>
        <item>
            <title>Genetic bases of mitochondrial respiratory chain disorders.</title>
            <link>http://www.medworm.com/index.php?rid=3201972&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20093061%26dopt%3DAbstract</link>
            <description>Authors: R&amp;#xF6;tig A
    Oxidative phosphorylation - ATP synthesis by the oxygen-consuming respiratory chain (RC) - supplies most organs and tissues with a readily usable energy source, and is already fully functioning at birth. This means that, in theory, RC deficiency can give rise to any symptom in any organ or tissue at any age and with any mode of inheritance, due to the two-fold genetic origin of RC components (nuclear DNA and mitochondrial DNA). It has long been erroneously believed that RC disorders originate from mutations of mtDNA as, for some time, only mutations or deletions of mtDNA could be identified. However, the number of disease-causing mutations in nuclear genes is now steadily growing. These genes not only encode the various subunits of each complex, but also the ancil...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3201972</comments>
            <pubDate>Tue, 19 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3201972</guid>        </item>
        <item>
            <title>Exodontia may improve glycemic control of diabetic patients with periodontitis.</title>
            <link>http://www.medworm.com/index.php?rid=3190014&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20080427%26dopt%3DAbstract</link>
            <description>Authors: Friedlander AH
    
    PMID: 20080427 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3190014</comments>
            <pubDate>Fri, 15 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3190014</guid>        </item>
        <item>
            <title>When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009.</title>
            <link>http://www.medworm.com/index.php?rid=3179548&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20074990%26dopt%3DAbstract</link>
            <description>When to treat a diabetic patient using an external insulin pump. Expert consensus. Soci&amp;#xE9;t&amp;#xE9; francophone du diab&amp;#xE8;te (ex ALFEDIAM) 2009.
    Diabetes Metab. 2010 Jan 12;
    Authors: Lassmann-Vague V, Clavel S, Guerci B, Hanaire H, Leroy R, Loeuille GA, Mantovani I, Pinget M, Renard E, Tubiana-Rufi N
    For years, external insulin pumps have enjoyed proven efficacy as an intensive diabetes treatment to improve glycaemic control and reduce hypoglycaemia. Since the last ALFEDIAM guidelines in 1995, however, basal-bolus treatment using a combination of long- and short-acting insulin analogues have emerged and could challenge, at a lower cost, the efficacy of pumps using rapid-acting insulin analogues, considered the 'gold standard' of insulin treatment. Nevertheless, given its th...</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3179548</comments>
            <pubDate>Tue, 12 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3179548</guid>        </item>
        <item>
            <title>Association of increased maternal ferritin levels with gestational diabetes and intra-uterine growth retardation.</title>
            <link>http://www.medworm.com/index.php?rid=3179547&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20074991%26dopt%3DAbstract</link>
            <description>CONCLUSION: Elevated maternal ferritin is not a reflection of excess iron stores, but is related to an increased risk of GDM or IUGR. Also, maternal ferritin levels are not associated with either neonatal iron status or neonatal outcomes.
    PMID: 20074991 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3179547</comments>
            <pubDate>Tue, 12 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3179547</guid>        </item>
        <item>
            <title>Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): Absence of rapid beta-cell loss in patients with tight metabolic control.</title>
            <link>http://www.medworm.com/index.php?rid=3167541&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20060765%26dopt%3DAbstract</link>
            <description>CONCLUSION: LADA patients demonstrate lower residual beta-cell function than do type 2 diabetes patients. However, those who achieve tight metabolic control do not present with a rapid decline in beta-cell function. Further studies are needed to determine the optimal treatment strategy in such patients.
    PMID: 20060765 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3167541</comments>
            <pubDate>Thu, 07 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3167541</guid>        </item>
        <item>
            <title>Activities of cyclooxygenases, and levels of prostaglandins E(2) And F(2alpha), in fetopathy associated with experimental diabetic gestation.</title>
            <link>http://www.medworm.com/index.php?rid=3143296&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20045370%26dopt%3DAbstract</link>
            <description>CONCLUSION: The increased production of PGF(2alpha) probably proceeds, at least in part, independently of the COX pathway and via the isoprostane route. However, it is unclear whether the relatively high levels of PGF(2alpha) are causally related to, or simply coincidental with, fetal malformation.
    PMID: 20045370 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3143296</comments>
            <pubDate>Wed, 30 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3143296</guid>        </item>
        <item>
            <title>DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients.</title>
            <link>http://www.medworm.com/index.php?rid=3126989&amp;cid=s_35512_15_f&amp;fid=35512&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20036596%26dopt%3DAbstract</link>
            <description>CONCLUSION: These results indicate the presence of significant lipid peroxidation, protein oxidation and oxidative DNA damage in patients with diabetes. Perturbation of glucose homoeostasis was associated with an increase in oxidants and a concomitant decrease of antioxidant enzymes in the type 2 diabetic patients' blood. The present study suggests that the status of oxidant-antioxidant imbalance may be one of the mechanisms leading to the DNA damage detected in the lymphocytes of type 2 diabetic patients.
    PMID: 20036596 [PubMed - as supplied by publisher] (Source: Diabetes and Metabolism)</description>
            <author>Diabetes and Metabolism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3126989</comments>
            <pubDate>Thu, 24 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3126989</guid>        </item>
    </channel>
</rss>

